Literature DB >> 16565685

The treatment of facial palsy from the point of view of physical and rehabilitation medicine.

T S Shafshak1.   

Abstract

There are evidences to support recommending the early intake of prednisone (in its appropriate dose of 1 mg/kg body weight for up to 70 or 80 mg/day) or the combined use of prednisone and acyclovir (or valacyclovir) within 72 h following the onset of paralysis in order to improve the outcome of Bell's palsy (BP). Although there may be a controversy about the role of physiotherapy in BP or facial palsy, it seemed that local superficial heat therapy, massage, exercises, electrical stimulation and biofeedback training have a place in the treatment of lower motor facial palsy. However, each modality has its indications. Moreover, some rehabilitative surgical methods might be of benefit for some patients with traumatic facial injuries or long standing paralysis without recovery, but early surgery in BP is usually not recommended. However, few may recommend early surgery in BP when there is 90-100% facial nerve degeneration. The efficacy of acupuncture, magnetic pellets and other modalities of physiotherapy needs further investigation. The general principles and the different opinions in treating and rehabilitating facial palsy are discussed and the need for further research in this field is suggested.

Entities:  

Mesh:

Year:  2006        PMID: 16565685

Source DB:  PubMed          Journal:  Eura Medicophys        ISSN: 0014-2573


  12 in total

1.  Efficacy of high and low level laser therapy in the treatment of Bell's palsy: a randomized double blind placebo-controlled trial.

Authors:  Mohamed Salaheldien Mohamed Alayat; Ahmed Mohamed Elsodany; Amir Abdel Raouf El Fiky
Journal:  Lasers Med Sci       Date:  2013-05-26       Impact factor: 3.161

2.  Puckering and blowing facial expressions in people with facial movement disorders.

Authors:  Rachel L Denlinger; Jessie M VanSwearingen; Jeffrey F Cohn; Karen L Schmidt
Journal:  Phys Ther       Date:  2008-07-10

3.  Epidemiology of Bell's palsy in an Italian Health District: incidence and case-control study.

Authors:  S Monini; A I Lazzarino; C Iacolucci; A Buffoni; M Barbara
Journal:  Acta Otorhinolaryngol Ital       Date:  2010-08       Impact factor: 2.124

Review 4.  Management of peripheral facial nerve palsy.

Authors:  Josef Finsterer
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-03-27       Impact factor: 2.503

5.  Acupuncture for the sequelae of Bell's palsy: a randomized controlled trial.

Authors:  Hyo-Jung Kwon; Jun-Yong Choi; Myeong Soo Lee; Yong-Suk Kim; Byung-Cheul Shin; Jong-In Kim
Journal:  Trials       Date:  2015-06-03       Impact factor: 2.279

6.  Recovery from Bell Palsy after Transplantation of Peripheral Blood Mononuclear Cells and Platelet-Rich Plasma.

Authors:  Istvan Seffer; Zoltan Nemeth
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-06-29

7.  Protocol for randomized controlled trial of electric stimulation with high-volt twin peak versus placebo for facial functional recovery from acute Bell's palsy in patients with poor prognostic factors.

Authors:  Myriam Loyo; Margaret McReynold; Jess C Mace; Michelle Cameron
Journal:  J Rehabil Assist Technol Eng       Date:  2020-12-10

8.  Literature study on clinical treatment of facial paralysis in the last 20 years using Web of Science: Comparison between rehabilitation, physiotherapy and acupuncture.

Authors:  Xiaoge Zhang; Ling Feng; Liang Du; Anxiang Zhang; Tian Tang
Journal:  Neural Regen Res       Date:  2012-01-15       Impact factor: 5.135

9.  Neuromuscular electrical stimulation and shortwave diathermy in unrecovered Bell palsy: A randomized controlled study.

Authors:  Nicola Marotta; Andrea Demeco; Maria Teresa Inzitari; Maria Giovanna Caruso; Antonio Ammendolia
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

10.  The efficacy of laser therapy in patients with facial palsy: A protocol for systematic review and meta-analysis.

Authors:  Jung-Hyun Kim; Yeon-Cheol Park; Byung-Kwan Seo; Yong-Hyeon Baek; Bonhyuk Goo; Sang-Soo Nam
Journal:  Medicine (Baltimore)       Date:  2020-08-21       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.